Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Voco Orchard Singapore, an IHG Hotel

Jul 16, 2024 8:30 AM - Jul 17, 2024 5:30 PM

581, Orchard Road, Singapore 238883, Singapore

2024 DIA Singapore Annual Meeting

Cultivating Synergies in Clinical Research and the Regulatory Environment to Innovate Healthcare


The rapid evolution of drug development and technology, coupled with regulatory advances have created new opportunities and challenges in healthcare. It is critical for regulators, academia, patients, and industries to collaborate closely to ensure an evolving and robust regulatory ecosystem that enables accelerated and cost-effective access to innovative healthcare solutions. This year, DIA Singapore Annual Meeting aims to bring regulators, patient representatives and industries to share and discuss ways in cultivating synergies in clinical research and the regulatory environment to innovate healthcare in APAC. Come join us and be a part of the discussions to explore the challenges and actions that stakeholders in APAC can adopt to ensure transformations in the healthcare evolution.

View Program

Featured topics

  • Future regulatory ecosystem
  • Accelerating and Streamlining Accelerating Procedures
  • Drug Development and Innovation in Clinical Research
  • New Regulatory Fields and Trends
  • The influence of emerging regulatory strategies and trends on the surveillance of medicines after they have been approved
  • Clinical Research Regulations


Want to learn more about 2024 DIA Singapore Annual Meeting? You've come to the right site!


Learning objectives

• Receive updates from senior regulators how healthcare products are regulated, what actions/ plans they have for regulating innovative products and clinical trials, and their collaborations with key stakeholders.

• Hear the dialogues between regulators, patient representatives and industries on Clinical Research and the Product Registration topics.

• Receive the information on hot regulatory topics, such as ICH guidelines, AI, and new technologies adopted in R&D.

• ASEAN Townhall: Hear deliberation about the topics discussed at this DIA Singapore from the ASEAN countries regulators.

• Network with regulators, patient representatives, clinical development, pharmacovigilance and regulatory affairs professionals from industries.

Program Committee

  • Finny  Liu, MSc, RPh
    Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
    Roche, Singapore
  • Helene  Sou, MSc, RAC
    Helene Sou, MSc, RAC Director, Growth and Emerging Markets
    Takeda, Singapore
  • Audrey  Ooi, MSc
    Audrey Ooi, MSc Head- Business Development
    Clinical Research Malaysia, Malaysia
  • Ellyne  Setiawan, MPharm
    Ellyne Setiawan, MPharm Head of Research & Development Quality (Asia Pacific),
    Daiichi Sankyo Singapore Pte. Ltd., Singapore
  • Jack  Wong
    Jack Wong Founder
    ARPA (Asia Regulatory Professionals Association) , Singapore
  • Martin  Lim, MBA, MS
    Martin Lim, MBA, MS Co-Founder and CEO
    ONWARD Health Research, Singapore
  • Sannie S Foong Chong, PhD
    Sannie S Foong Chong, PhD Senior Director, Global Regulatory Policy
    MSD International, Singapore
  • Senthil  Sockalingam
    Senthil Sockalingam M.D, Head of IQVIA Biotech, JAPAC, Chief Medical Officer, IQVIA, APAC
    IQVIA, Singapore
  • Thean Soo  Lo
    Thean Soo Lo
    Regulatory Affairs Management Consultant, Singapore
  • Vicky  Hsu
    Vicky Hsu Senior Vice President, Head of Project Leadership and Biotech Operations Asia
    Parexel International, Singapore
  • Shogo  Nakamori, MBA, MSc, RPh
    Shogo Nakamori, MBA, MSc, RPh Senior Vice President & Managing Director, DIA Japan, Korea, and Singapore
    DIA, Japan
  • Carley  Kim, MBA
    Carley Kim, MBA Country Manager of Korea & Singapore
    DIA, United States
  • Jing Ping  Yeo, PhD
    Jing Ping Yeo, PhD Head - Transformation
    George Clinical, Singapore
  • Fengyun(Vicky)  Han
    Fengyun(Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
    Johnson & Johnson Pte. Ltd., Singapore
  • Shun  Jin, MBA
    Shun Jin, MBA Head, Regulatory Affairs, APMA
    Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
  • Kum Cheun  Wong, PharmD
    Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
    Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
  • Seasea  GAO, MD, PhD
    Seasea GAO, MD, PhD Executive Medical Director
    JAPAC Merck, Singapore

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.